Lucid Diagnostics (LUCD) Non Operating Interest Expenses (2021 - 2026)

Lucid Diagnostics (LUCD) has reported Non Operating Interest Expenses for 5 consecutive years, with $4000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses fell 33.33% year-over-year to $4000.0; the trailing twelve-month figure through Jun 2026 stood at $18000.0 (down 21.74% YoY), and the FY2025 full-year result was $22000.0, down 15.38% from the prior year.
• Non Operating Interest Expenses eased to $4000.0 in Q2 2026 per LUCD's latest filing, from $6000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $223000.0 in Q2 2023 and bottomed at $1000.0 in Q3 2024.
• Historically, Non Operating Interest Expenses has averaged $33928.6 across 4 years, with a median of $6500.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses tumbled 99.33% in 2024, then soared 100.0% in 2025.
• Over 4 years, Non Operating Interest Expenses stood at $11000.0 in 2023, then tumbled by 36.36% to $7000.0 in 2024, then dropped by 14.29% to $6000.0 in 2025, then slumped by 33.33% to $4000.0 in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $4000.0, $6000.0, and $6000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.